[1] Alexopoulou A, Koskinas J, Deutsch M,et al. Acute liver failure as the initial manifestation of hepatic infiltration by a solid tumor: report of 5 cases and review of the literature[J].Tumori,2016, 92(4): 354-357. [2] Bensch F, Lamberts LE, Smeenk MM, et al. 89Zr-lumretuzumab PET imaging before and during HER3 antibody lumretuzumab treatment in patients with solid tumors[J].Clin Cancer Res,2017, 23(20): 6128-6137. [3] Ghatalia P, Morgan CJ, Sonpavde G. Meta-analysis of regression of advanced solid tumors in patients receiving placebo or no anti-cancer therapy in prospective trials[J].Crit Rev Oncol Hematol,2016, 98: 122-136. [4] Von Hoff DD, Mita MM, Ramanathan RK, et al. Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors[J].Clin Cancer Res,2016, 22(13): 3157-3163. [5] Shao Y, Gu W, Ning Z, et al. Evaluating the Prognostic Value of microRNA-203 in Solid Tumors Based on a Meta-Analysis and the Cancer Genome Atlas (TCGA) Datasets[J].Cell Physiol Biochem,2017, 41(4): 1468-1480. [6] Stylianopoulos T. Intelligent drug delivery systems for the treatment of solid tumors[J].Eur J Nanomed,2016, 8(1): 9-16. [7] Hau HM, Kloss A, Wiltberger G, et al. The challenge of liver resection in benign solid liver tumors in modern times - in which cases should surgery be done [J]?Z Gastroenterol,2017, 55(7): 639-652. [8] Mocan L, Matea C, Tabaran FA, et al. Selective ex vivo photothermal nano-therapy of solid liver tumors mediated by albumin conjugated gold nanoparticles[J].Biomaterials,2017,119: 33-42. [9] Parsons DW, Roy A, Yang Y, et al. Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors[J].JAMA Oncol,2016, 2(5):361. [10] Moeendarbari S, Tekade R, Mulgaonkar A, et al. Theranostic nanoseeds for efficacious internal radiation therapy of unresectable solid tumors[J].Sci Rep,2016, 6: 20614.
2018, Vol. 35 
